Aller au contenu principal
Profil bibliographique

José Luis Subiza

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

167Publications signalées
4345Citations signalées
2Affiliations récentes

Les institutions déclarées

Les domaines associés

Allergic Rhinitis and SensitizationContact Dermatitis and AllergiesImmune responses and vaccinationsFood Allergy and Anaphylaxis ResearchDermatology and Skin Diseases

Les publications récentes

Accès ouvert 2026 article OpenAlex

Proteomic profiling of Juniperus oxycedrus and Cupressus arizonica pollen reveals quantitative interspecies differences in the IgE-binding protein repertoire associated with Mediterranean Cupressaceae allergy

Sandra Sivill, José Carlos Hernández-Walias, J Igea, Jose Alejandro Lemus Calderon et autres

Background Diagnosis and allergen-specific immunotherapy for Mediterranean allergy rely on extracts standardized to group-1 allergens, such as Cup a 1 from Cupressus arizonica , potentially overlooking interspecies variability. The native species Juniperus oxycedrus , widespread in Spain, may contribute to sensitization, but …

es, us (code pays fourni par la source)

0 citations Frontiers in Allergy
Accès ouvert 2026 article OpenAlex

Circulating carbohydrate antigen Ca10H predicts favorable prognosis in colorectal cancer

Pablo Mata-Martínez, Laura Bravo-Robles, Laura Hurtado-Navarro, Laura Córdoba et autres

Non-invasive biomarkers for early detection and prognosis of colorectal cancer (CRC) remain an unmet clinical need. In this work, we investigated Ca10H, a novel circulating carbohydrate antigen, as a plasma biomarker with prognostic value in CRC. Plasma Ca10H was quantified by ELISA …

es, us (code pays fourni par la source)

0 citations Scientific Reports
Accès ouvert 2026 preprint OpenAlex

Short-Course Subcutaneous Immunotherapy with Mannan-Conjugated Birch Pollen Allergoids: Consistent Clinical and Immunological Improvements

E Raskopf, Sofia Passamera, Ludger Klimek, Oliver Pfaar et autres

Background: The mannan-conjugated birch pollen polymerised allergoid EP-088_T502 has previously been shown to reduce allergic symptoms and anti-allergic medication use during the birch pollen season. This confirmatory phase III trial aimed to evaluate the efficacy, safety, tolerability, and immunologic effects of six …

0 citations Preprints.org
Accès ouvert 2026 article OpenAlex

Sustained Clinical Improvement in Birch Pollen Allergy After Two Pre‐Seasonal Short Courses of Allergen‐Specific Immunotherapy: A Long‐Term Open‐Label Extension Study

Ralph Mösges, Friederike Hüffmeier, Ludger Klimek, Oliver Pfaar et autres

BACKGROUND: Mannan-conjugated allergoids represent an effective option for treating allergic diseases. This study evaluated the clinical impact of the mannan-conjugated, polymerised birch pollen allergoid EP-088_T502 in patients with birch pollen-induced allergic rhinoconjunctivitis over 3 years. METHODS: Following up to a double-blind, placebo-controlled …

de, es (code pays fourni par la source)

1 citation Clinical & Experimental Allergy
Accès ouvert 2025 article OpenAlex

Clinical Efficacy of One Short Course of Mannan-Conjugated Birch Pollen Allergoid Immunotherapy: A Comparative Evaluation After Prior Placebo Treatment

Sandra del Pozo, Natascha Wahrhusen, Oliver Pfaar, E Raskopf et autres

Background/Objectives: Allergen immunotherapy (AIT) with chemically modified allergoids represents a promising approach for the treatment of allergic rhinoconjunctivitis. This post hoc analysis investigated the clinical efficacy of a mannan-conjugated birch pollen allergoid (T502) by comparing outcomes in patients who received placebo in …

es, de (code pays fourni par la source)

2 citations Journal of Clinical Medicine
Accès ouvert 2025 preprint OpenAlex

Clinical Efficacy of One Short Course of Mannan-Conjugated Birch Pollen Allergoid Immunotherapy: A Comparative Evaluation After Prior Placebo Treatment

Sandra del Pozo, Natascha Wahrhusen, Oliver Pfaar, E Raskopf et autres

Background/Objectives: Allergen immunotherapy (AIT) with chemically modified allergoids represents a promising approach for the treatment of allergic rhinoconjunctivitis. This post-hoc analysis investigated the clinical efficacy of a mannan-conjugated birch pollen allergoid (T502) by comparing outcomes in patients who received placebo in one …

es, de (code pays fourni par la source)

0 citations Preprints.org
Accès ouvert 2025 article OpenAlex

Peptides Derived from α-Tubulin Induce Functional T Regulatory Cells

Tara Fiyouzi, José Luis Subiza, Esther M. Lafuente, Pedro A. Reche

Regulatory T (Treg) cells are essential for maintaining self-tolerance and regulating immune responses. In this study, we report the identification of Treg cell epitopes in human α-tubulin that were capable of enhancing IL-10-producing Foxp3+ Treg cells and LAG-3+CD49b+FoxP3− Tr1 cells in vitro, …

es (code pays fourni par la source)

1 citation International Journal of Molecular Sciences
Accès ouvert 2025 article OpenAlex

A mucosal vaccine prevents eosinophilic allergic airway inflammation by modulating immune responses to allergens in a murine model of airway disease

Carmen Sevilla‐Ortega, Alba Angelina, Leticia Martín‐Cruz, Mario Pérez‐Diego et autres

Allergic sensitization and viral infections are risk factors for asthma development and progression. Sublingual vaccination with MV130, a whole heat-inactivated polybacterial preparation, protects against viral infections, but its impact on allergic sensitization and asthma development remains unknown. Here we show MV130 prevents …

es (code pays fourni par la source)

9 citations Nature Communications
Accès ouvert 2025 article OpenAlex

Vaccines and adjuvants in allergen specific immunotherapy: current status and future directions

Yiwu Zheng, José Luis Subiza

Allergen specific immunotherapy (AIT) has a history spanning over 110 years and represents the only disease-modifying treatment for allergic diseases, with potential preventive effects. Nevertheless, the broader application of AIT is limited by the inherent drawbacks of natural allergen extracts, such as …

cn, es (code pays fourni par la source)

9 citations Allergy medicine.
Accès ouvert 2025 article OpenAlex

Polymerised mite allergoids with glutaraldehyde reduce proteolytic activity and enhance the stability of allergen mixtures: a proof of concept with grass mixtures

José Ignacio Tudela, Irene Soria, Eva Abel-Fernández, José Fernando Cantillo et autres

Background: Polysensitized patients require allergen immunotherapy (AIT) targeting multiple allergens. However, combining allergen extracts can lead to instability and reduced efficacy particularly due to the high proteolytic activity of house dust mite (HDM) allergens. While is known that glutaraldehyde cross-linking may reduce …

es (code pays fourni par la source)

2 citations Frontiers in Allergy
Accès ouvert 2025 article OpenAlex

Microbiota translocation following intestinal barrier disruption promotes Mincle-mediated training of myeloid progenitors in the bone marrow

Iñaki Robles‐Vera, Aitor Jarit-Cabanillas, Paola Brandi, María Martínez‐López et autres

mice showed impaired TI upon E. faecalis administration and reduced pathology following DSS treatment. Thus, Mincle sensing of E. faecalis induces TI that may have long-term effects on pathologies associated with increased gut permeability.

es (code pays fourni par la source)

53 citations Immunity
Accès ouvert 2025 preprint OpenAlex

Treg cell epitopes from α -tubulin: discovery and immunomodulatory features

Tara Fiyouzi, José Luis Subiza, Esther M. Lafuente, Pedro A. Reche

Abstract Regulatory T (Treg) cells are pivotal in maintaining self-tolerance and controlling immune responses. In this study, we investigated potential Treg cell epitopes in human α-tubulin that were selected in silico for their promiscuous binding to class II human leukocyte antigens and …

es (code pays fourni par la source)

1 citation bioRxiv (Cold Spring Harbor Laboratory)

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.